BagdadeJ.D., CarrettoA., AlbersJ.Effects of chronic uremia, hemodialysis and renal transplantation on plasma lipids and lipoproteins in man. J Lab Med1976; 1987: 37–48.
2.
ChanM.K., VargheseZ., MoorheadJ.F.Lipids abnormalities in uremia, dialysis and transplantation. Kidney Int1981; 9: 625–37.
3.
LacourB., DruekeT.B.Lipid metabolism. In: MassryS.G., ChassockR.J., eds. Textbook of Nephrology.Baltimore, Williams & Wilkins1989; vol. 2: 1228–38.
4.
KasiskeB.L., ClearlyM.P., KeanW.F.Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med1985; 106: 598–604.
5.
MoorheadJ.F., El-NahasM., ChanM.K., VargheseZ.Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet1982; 11: 1309–11.
6.
KeaneW.K., KasiskeB.L., O' DonneiM.P.Lipids and progressive glomerulosclerosis. Am J Nephrol1988; 8: 261–71.
7.
GreenD., StoneN.J., KrumlovaskyF.A.Putative atherogenic factors in patients with chronic renal failure. Prog Cardiovasc Dis1983; 26: 133–44.
8.
GrutzmakerP., MarzW., PeshkeB., GrossW., SchoeppeL.Lipoproteins and apolipoproteins during the progression of renal disease. Nephron1988; 50: 103–11.
9.
AttmanP.O., AlaupovichP.Lipid and apolipoprotein profiles of uremic dyslipoproteinemia. Relation to renal function and dialysis. Nephron1991; 54: 401–10.
10.
BergesioF., MonzaniG., CiutiR.Lipids and apolipoproteins change during progression of chronic renal failure. Clin Nephrol1992; 38: 264–70.
11.
AlaupovichP., McConathyW.J., FasmireJ., TavellaM., MardJ.M.Profiles of particles in dyslipoproteinemias. Clin Chem1988; 33: B13–27.
12.
BrunzellJ.D., SnidermanA.D., AlbersJ., KwiterovichP.O.Apolipoproteins B and A1 and coronary Artery disease in humans. Atherosclerosis1984; 4: 79–83.
13.
MassyZ.A., JungersP., RoulletJ.B., DruerkeT., LacourB.Disturbances of apolipoprotein distribution in lipoproteins of uremic patients. J Nephrol1993; 6: 153–8.
14.
IzzoC., GrilloF., MuradorF.Improved method for determination of high-density lipoprotein cholesterol. I. Isolation of HDL by use of polyethylene glycol 6000. Clin Chem1981; 27: 371–4.
15.
WielandH., SeidelD.A simple specific method for precipitation of low-density lipoproteins. J Lipid Res1983; 23: 904–9.
16.
DemackerP.N., HijmansA.G., BrenninkmeijrB.J., JansenA.D.P., Van'T LaarA.Five methods for determining low density lipoprotein cholesterol compared. Cli Chem1984; 30: 1797–800.
17.
WeinstockN., BatholoneM.Determination of Apo Al by kinetic nephelometry. Biochim Biophys Acta1981; 663: 279–88.
DolphinP.J.Lipoprotein metabolism and the role of apolipoproteins as metabolic programmers. Can J Biochem Cell Biol1985; 63: 850–69.
20.
StrapansI., FeltsJ.M., ZacherleB.Apoprotein composition of plasma lipoproteins in uremic patients on hemodialysis. Clin Chim Acta1979; 93: 135–43.
21.
AttmanP.O., AlaupovichP., GustafsonA.Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int1987; 32: 368–75.
22.
McCoshE.J., SolangiK., RivesJ.M., GoodmanA.Hypertriglyceridemia in chronic renal insufficiency. Am J Clin Nutr1975; 28: 1936–43.
23.
SamuelssonO., AttmanP.O., Knight-GibsonC.Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant1994; 9: 1580–5.
24.
WindierE., HavelR.J.Inhibitory of triglyceride-rich lipoproteins and their remnants by perfused rat liver. Lipid Res1985; 27: 556–65.
25.
NesterlP.J., FidgeN.H., TanM.H.Increased lipoprotein-remnant formation in chronic renal failure. N Engl J ed, 1982; 397: 329–33.
26.
RonD., OrenI., AviramM., BetterO.S., BrookJ.G.Accumulation of lipoprotein remnants in patients with chronic renal failure. Atherosclerosis1983; 46: 67–75.
27.
CamejoG., RieraG., LeeM., LopezF.Lipoprotein structural abnormalities in chronic renal failure with and without hemodialysis. Biomed Biochim Acta1988; 4: 239–45.
28.
WakabayashiY., OkuboM., ShimadeH., KoideA., MamumoF., NakamuraH.Decreased VLDL Apoprotein CII/Apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic dialysis treatment. Metabolism1987; 38: 601–2.
29.
ChanM.K., VargheseZ., PersaudW., BailloodR.A., MoorheadJ.F.Hyperlipidemia in patients on maintenance hemo-and peritoneal dialysis: the relative pathogenetic roles of triglycerides production and triglycerides removal. Clin Nephrol1992; 37: 183–90.
30.
RitzE., AugustinJ., BommerJ., GuassoA., HaberboschW.Should hyperlipemia of renal failure be treated?Kidney Int1985; 28(Suppl): 84–7.
31.
GoldbergA.C., SchonfeldG.Effect of diet on lipoprotein metabolism. Ann Rev Nutr1985; 5: 195–212.
32.
GrundyS.M.Management of hyperlipidemia of kidney disease. Kideny Int1990; 37: 847–53.
33.
AppelG.Lipid abnormalities in renal disease. Kidney Int1991; 39: 169–83.
